Understanding the US Physician Payments Sunshine Act is essential for life sciences companies. The Latham team provides a compliance roadmap for companies preparing for their first launch and report.
The US Physician Payments Sunshine Act requires life sciences companies to publicly report payments, transfers of value, and ownership interests. In the first episode of our Shining a Light on the Sunshine Act and Transparency Requirements series, Washington, D.C. counsel Nicole Liffrig Molife and associate Megan Lich walk listeners through the fundamentals of Sunshine Act compliance, including who is required to report, what types of payments and ownership interests must be reported, and key deadlines and compliance strategies.
Listen here or subscribe via Apple Podcasts, Spotify, or anywhere else you listen to podcasts.
